Regulators of G protein signaling in cardiovascular function during pregnancy
Author(s) -
Katherine J Perschbacher,
Guorui Deng,
Rory A. Fisher,
Katherine N. GibsonCorley,
Mark K. Santillan,
Justin L. Grobe
Publication year - 2018
Publication title -
physiological genomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.078
H-Index - 112
eISSN - 1531-2267
pISSN - 1094-8341
DOI - 10.1152/physiolgenomics.00037.2018
Subject(s) - biology , signal transduction , pathogenesis , regulator , second messenger system , preeclampsia , regulator of g protein signaling , receptor , g protein coupled receptor , protein family , messenger rna , rgs2 , microbiology and biotechnology , g protein , bioinformatics , pregnancy , genetics , gene , gtpase activating protein , immunology
G protein-coupled receptor signaling mechanisms are implicated in many aspects of cardiovascular control, and dysfunction of such signaling mechanisms is commonly associated with disease states. Investigators have identified a large number of regulator of G protein signaling (RGS) proteins that variously contribute to the modulation of intracellular second-messenger signaling kinetics. These many RGS proteins each interact with a specific set of second-messenger cascades and receptor types and exhibit tissue-specific expression patterns. Increasing evidence supports the contribution of RGS proteins, or their loss, in the pathogenesis of cardiovascular dysfunctions. This review summarizes the current understanding of the functional contributions of RGS proteins, particularly within the B/R4 family, in cardiovascular disorders of pregnancy including gestational hypertension, uterine artery dysfunction, and preeclampsia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom